Experts name 3 ASX 200 shares to buy now

Here are three ASX 200 shares named as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're interested in adding some S&P/ASX 200 Index (ASX: XJO) shares to your portfolio in August, then the three listed below could be worth considering.

These ASX 200 shares have all been named as buys recently. Here's what you need to know about them:

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.

Image source: Getty Images

Cochlear Limited (ASX: COH)

The first ASX 200 share to look at is Cochlear. It is one of the world's leading hearing solutions companies. It could be a great long term option for investors thanks to its leadership position in an industry with high barriers of entry and experiencing favourable tailwinds such as ageing populations.

Goldman Sachs is a fan of Cochlear. Its analysts currently have a buy rating and $237.00 price target on its shares. This compares favourably to the latest Cochlear share price of $212.64.

NEXTDC Ltd (ASX: NXT)

Another ASX 200 share that could be in the buy zone is NextDC. It is a leading data centre operator with a collection of world class centres that are benefiting from the ongoing structural shift to the cloud. Together with its potential expansion into Asia and Edge (regional) data centres, NextDC has been tipped to grow strongly in the coming years by a number of brokers.

One of those is Citi, which currently has a buy rating and $14.55 price target on its shares. This is materially higher than the latest NextDC share price of $11.60.

SEEK Limited (ASX: SEK)

A final ASX 200 share for investors to look at is leading job listings company, Seek. It appears well-positioned for growth in the coming years thanks to its leadership position, strong pricing power, and exposure to Australia's recovery from the pandemic.

The team at Credit Suisse is positive on Seek. Its analysts currently have an outperform rating and $36.90 price target on its shares. This implies significant upside from the current Seek share price of $21.49.

Motley Fool contributor James Mickleboro has positions in NEXTDC Limited and SEEK Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man looking at his laptop and thinking.
Blue Chip Shares

These ASX blue chips now look too cheap to ignore

These blue chips could be worth a closer look after sharp declines.

Read more »

Young woman thinking with laptop open.
Blue Chip Shares

Why is everyone selling Wesfarmers shares?

It looks like the retail conglomerate fell out of favour with investors this year.

Read more »

Four business people wearing formal business suits and ties walk abreast on a wide paved surface with their long shadows falling on the ground ahead of them.
Blue Chip Shares

How did these ASX blue-chip shares perform in March?

Did these blue-chips beat the market in March?

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Blue Chip Shares

Are these ASX blue chips now too cheap to ignore?

Let's see why these shares could be seriously undervalued at current levels.

Read more »

A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
Blue Chip Shares

3 reasons to buy Wesfarmers shares today

The retail conglomerate is a no-brainer buy in my book.

Read more »

ASX shares buy Street signs stating 'Winners' and 'Losers' in front of urban backdrop
Blue Chip Shares

How are these 5 ASX share giants really tracking in 2026?

Some are struggling, while others are thriving, proving that opportunity is never far away.

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

My best blue-chip ASX 200 buys for April

Looking for quality in uncertain markets? These three ASX 200 shares stand out to me.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »